These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33978386)

  • 1. The Elevated Risk of Recurrent Clostridioides Difficile Infection in Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-analysis.
    Yang X; Huang Z; He J; Chen Y
    Clin Lab; 2021 May; 67(5):. PubMed ID: 33978386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
    Porcari S; Severino A; Rondinella D; Bibbò S; Quaranta G; Masucci L; Maida M; Scaldaferri F; Sanguinetti M; Gasbarrini A; Cammarota G; Ianiro G
    J Autoimmun; 2023 Dec; 141():103033. PubMed ID: 37085337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Porcari S; Baunwall SMD; Occhionero AS; Ingrosso MR; Ford AC; Hvas CL; Gasbarrini A; Cammarota G; Ianiro G
    J Autoimmun; 2023 Dec; 141():103036. PubMed ID: 37098448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Outcomes of Faecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
    Nicholson MR; Alexander E; Ballal S; Davidovics Z; Docktor M; Dole M; Gisser JM; Goyal A; Hourigan SK; Jensen MK; Kaplan JL; Kellermayer R; Kelsen JR; Kennedy MA; Khanna S; Knackstedt ED; Lentine J; Lewis JD; Michail S; Mitchell PD; Oliva-Hemker M; Patton T; Queliza K; Sidhu S; Solomon AB; Suskind DL; Weatherly M; Werlin S; de Zoeten EF; Kahn SA;
    J Crohns Colitis; 2022 Jun; 16(5):768-777. PubMed ID: 34788420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
    Cho S; Spencer E; Hirten R; Grinspan A; Dubinsky MC
    J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):343-347. PubMed ID: 30320666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metagenomic and bile acid metabolomic analysis of fecal microbiota transplantation for recurrent Clostridiodes difficile and/or inflammatory bowel diseases.
    Ramos RJ; Zhu C; Joseph DF; Thaker S; Lacomb JF; Markarian K; Lee HJ; Petrov JC; Monzur F; Buscaglia JM; Chawla A; Small-Harary L; Gathungu G; Morganstern JA; Yang J; Li J; Pamer EG; Robertson CE; Frank DN; Cross JR; Li E
    Med Res Arch; 2022 Oct; 10(10):. PubMed ID: 36618438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Lee MR; Kim ES
    Korean J Gastroenterol; 2022 Aug; 80(2):66-71. PubMed ID: 36004633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
    Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
    Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Recurrent
    Azimirad M; Yadegar A; Gholami F; Shahrokh S; Asadzadeh Aghdaei H; Ianiro G; Suzuki H; Cammarota G; Zali MR
    J Inflamm Res; 2020; 13():563-570. PubMed ID: 32982371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent
    van Lingen EE; Baunwall SSMD; Lieberknecht SSC; Benech NN; Ianiro GG; Sokol HH; Gasbarrini AA; Cammarota GG; Eriksen MMK; van der Meulen-de Jong AAE; Terveer EEM; Verspaget HHW; Vehreschild MM; Hvas CCL; Keller JJJ
    Therap Adv Gastroenterol; 2023; 16():17562848231156285. PubMed ID: 36910163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile in inflammatory bowel disease.
    Alhobayb T; Ciorba MA
    Curr Opin Gastroenterol; 2023 Jul; 39(4):257-262. PubMed ID: 37265220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response and changes in the fecal microbiota and metabolite levels after fecal microbiota transplantation in patients with inflammatory bowel disease and recurrent
    Osaki H; Jodai Y; Koyama K; Omori T; Horiguchi N; Kamano T; Funasaka K; Nagasaka M; Nakagawa Y; Shibata T; Ohmiya N
    Fujita Med J; 2021; 7(3):87-98. PubMed ID: 35111551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
    Gholam-Mostafaei FS; Yadegar A; Asadzadeh Aghdaei H; Shahrokh S; Ebrahimi Daryani N; Zali MR
    Acta Microbiol Immunol Hung; 2021 Aug; ():. PubMed ID: 34383708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.
    Madoff SE; Urquiaga M; Alonso CD; Kelly CP
    Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
    Spartz EJ; DeDecker LC; Fansiwala KM; Noorian S; Roney AR; Hakimian S; Sauk JS; Chen PH; Limketkai BN
    Aliment Pharmacol Ther; 2024 Jan; 59(1):89-99. PubMed ID: 37873878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease.
    You JHS; Jiang X; Lee WH; Chan PKS; Ng SC
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1515-1523. PubMed ID: 32017248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies.
    Chen T; Zhou Q; Zhang D; Jiang F; Wu J; Zhou JY; Zheng X; Chen YG
    J Crohns Colitis; 2018 May; 12(6):710-717. PubMed ID: 29528385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
    Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
    Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease.
    Reasoner SA; Nicholson MR
    Curr Gastroenterol Rep; 2023 Nov; 25(11):316-322. PubMed ID: 37646895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.